Evan's syndrome complicating multicentric Castleman's disease - dramatic response to rituximab
- 30 September 2004
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 73 (5), 384-385
- https://doi.org/10.1111/j.1600-0609.2004.00302.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatmentBlood, 2004
- Monoclonal antibodies in the treatment of autoimmune cytopeniasEuropean Journal of Haematology, 2004
- Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans SyndromeMayo Clinic Proceedings, 2003
- Rituximab therapy for HIV-associated Castleman diseaseBlood, 2003
- Anti-CD20 Therapy for Chronic Lymphocytic Leukemia-associated Autoimmune DiseasesLeukemia & Lymphoma, 2003
- Long-term remission of Kaposi sarcoma–associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapyBlood, 2001
- Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpuraBlood, 2001
- Systemic Castleman's disease in association with Evan's syndrome and vitiligoMedical and Pediatric Oncology, 1990